What GLP-1 Does United Healthcare Cover in 2026?
Published: · Last reviewed:
By The RX Index Editorial Team · Last verified: June 2026
What GLP-1 does United Healthcare cover? The honest answer is that it depends on why you're taking it. For type 2 diabetes, UnitedHealthcare's commercial drug list includes Ozempic, Mounjaro, Rybelsus, and Trulicity — with prior approval — and this is the most reliable coverage lane. For weight loss, Wegovy and Zepbound are covered only when your employer added a weight-loss drug benefit, which many plans skip. Compounded GLP-1s aren't covered.
If that already feels confusing, you're not imagining it. One coworker gets Ozempic covered; another gets a flat "no." Same insurance company, different rules. Here's the part almost nobody tells you: even on a plan that "doesn't cover weight-loss drugs," Wegovy and Zepbound can still be covered through a separate door — for heart disease, liver disease, or sleep apnea. So a "no" at the pharmacy counter isn't always the final word. We'll show you every door, using the exact rules from UnitedHealthcare's own 2026 policies.
This page is for you if:
You have UnitedHealthcare (often written "United Healthcare") or OptumRx, and you want to know which GLP-1 is actually worth asking your doctor about — before a visit, a denial, or a surprise price tag.
This page is not for you if:
You want a guaranteed dollar amount for your copay. No website can promise that, and we'll explain why in plain English below.
The RX Index is the independent GLP-1 decision resource that scores telehealth providers and treatment paths on clinical legitimacy, care quality, transparency, access, and cost, so readers can choose the path that fits their situation.
The 30-second answer: coverage by reason
UnitedHealthcare GLP-1 coverage comes down to your "lane" — the medical reason on the prescription. Diabetes drugs (Ozempic, Mounjaro, Rybelsus, Trulicity) sit in one lane and are widely listed with prior authorization. Weight-loss drugs (Wegovy, Zepbound, Saxenda) sit in a different lane your employer has to switch on. Heart, liver, and sleep-apnea diagnoses open separate lanes of their own.
| Your reason for the GLP-1 | The lane to check first | Likely first step |
|---|---|---|
| Type 2 diabetes | Ozempic, Mounjaro, Rybelsus, Trulicity, liraglutide | Prior authorization with proof of diabetes |
| Weight loss only | Wegovy or Zepbound — only if your plan added the weight-loss benefit | Confirm the benefit, then prior authorization |
| Weight loss + known heart disease | Wegovy (heart-risk rules) | Prior authorization under cardiovascular criteria |
| Obesity + sleep apnea | Zepbound (sleep-apnea rules) | Prior authorization under OSA criteria |
| Liver disease (MASH) | Wegovy injection (MASH rules) | Prior authorization with a liver-fibrosis test |
| Medicare Part D / Advantage | Medicare GLP-1 Bridge or standard Part D | Ask your provider about the Bridge (starts July 1, 2026) |
| Medicaid / UHC Community Plan | Your state's drug list | Check your state Medicaid formulary |
Hold onto one fact before you read on: being on UnitedHealthcare's drug list does not guarantee your specific plan pays for it. The difference between "listed" and "covered" is the mistake that trips up the most people — we explain it next.
The right GLP-1 provider isn't the same for everyone — it depends on your state, your insurance and formulary, whether you want an FDA-approved or compounded medication, your preferred treatment path (injection or oral), and your budget. Because a general answer can't resolve those for you, use The RX Index's Find My GLP-1 Path tool to get a personalized provider match with source-verified pricing before you choose.
What GLP-1 medications does United Healthcare cover?
UnitedHealthcare's commercial drug list includes the major diabetes GLP-1 medications — Ozempic, Mounjaro, Rybelsus, and Trulicity — typically with prior authorization and quantity limits. The weight-loss GLP-1s, Wegovy and Zepbound, are a separate story: coverage depends on whether your plan added a weight-loss drug benefit. Compounded semaglutide and tirzepatide are not covered.
A few quick definitions:
- GLP-1 — a class of medicines (like semaglutide and tirzepatide) that lower blood sugar and reduce appetite.
- Formulary / PDL — the list of drugs a plan may cover.
- PBM — the company that runs your drug benefit. UnitedHealthcare's is OptumRx.
- PA (prior authorization) — your doctor has to get the drug approved before the plan pays.
- QL (quantity limit) — a cap on how much you can get per fill.
- ST (step therapy) — you may have to try a lower-cost drug first.
The UnitedHealthcare GLP-1 Coverage Matrix (2026)
| Medication | FDA-approved for | UHC lane | Covered for diabetes? | Covered for weight loss? | Prior auth? |
|---|---|---|---|---|---|
| Ozempic (semaglutide) | Type 2 diabetes; heart-risk and kidney protection in diabetes | Diabetes | Listed with PA on the commercial drug list | No — not FDA-approved for weight loss | Yes |
| Mounjaro (tirzepatide) | Type 2 diabetes | Diabetes | Listed with PA on the commercial drug list | No | Yes |
| Rybelsus (oral semaglutide) | Type 2 diabetes | Diabetes | Listed as Tier 2 with PA and QL | No | Yes |
| Trulicity (dulaglutide) | Type 2 diabetes; heart-risk in diabetes | Diabetes | Listed with PA on the commercial drug list | No | Yes |
| Liraglutide (generic Victoza) | Type 2 diabetes | Diabetes | Generic often covered; brand Victoza typically excluded | No | Yes |
| Wegovy (semaglutide, pen or pill) | Weight loss; heart-risk; liver disease (MASH) | Weight loss + separate medical lanes | n/a | Only if your plan added the weight-loss benefit | Yes |
| Zepbound (tirzepatide) | Weight loss; obstructive sleep apnea | Weight loss + sleep-apnea lane | n/a | Only if your plan added the weight-loss benefit | Yes |
| Saxenda (liraglutide 3.0) | Weight loss | Weight loss | n/a | Only with the weight-loss benefit; less preferred now | Yes |
| Foundayo (orforglipron, oral) | Weight loss (FDA-approved April 2026) | Weight loss (being added) | n/a | Not in May 2026 policy; adding eff. Sept 1, 2026. In Medicare Bridge from July 1, 2026. | Yes |
| Compounded semaglutide / tirzepatide | Not FDA-approved | Not covered | No | No | n/a |
Sources: UnitedHealthcare Commercial Prescription Drug List (eff. May 1, 2026); diabetes GLP-1 PA policy Program 2025 P 1332-7; weight-loss policy Program 2026 P 1114-20; sleep-apnea policy 2025 P 1475-2; cardiovascular/MASH policy 2026 P 1445-4.
"Listed" is not the same as "covered" — read this before you celebrate or panic
UnitedHealthcare's drug list is a menu, not a promise. The plan itself states that the list does not define what any individual member's benefit actually pays for. Your specific plan documents — especially what your employer chose — make the final call.
That one fact explains the confusion you've run into. Your coworker gets Ozempic covered; you get denied. Same insurance company, different plans. The useful question is never "Does UnitedHealthcare cover GLP-1s?" It's "Does my plan cover this drug for my reason?"
Does United Healthcare cover Ozempic, Mounjaro, Rybelsus, or Trulicity for diabetes?
Yes, for most plans — if you have documented type 2 diabetes and your doctor gets prior authorization. UnitedHealthcare's diabetes GLP-1 policy approves Ozempic, Mounjaro, Rybelsus, Trulicity, and generic liraglutide once your records confirm type 2 diabetes. Approvals are issued for 12 months.
Per UnitedHealthcare's diabetes GLP-1 policy, your prior authorization clears when your chart shows one of these:
- An A1C of 6.5% or higher (your average blood sugar over about three months), or
- A fasting blood sugar of 126 mg/dL or higher, or
- A 2-hour glucose of 200 mg/dL or higher on a glucose-tolerance test, or
- A random blood sugar of 200 mg/dL or higher with classic diabetes symptoms, or
- A standing type 2 diabetes diagnosis (treated more than two years ago) noted in your chart.
That's the diabetes lane: no BMI minimum, no "try and fail" diet rule — just solid proof of type 2 diabetes.
Does United Healthcare cover Wegovy or Zepbound for weight loss?
Sometimes — but only when your plan includes a weight-loss drug benefit. UnitedHealthcare's weight-loss medication program is optional: it applies only to employers and plans that elected to cover drugs like Wegovy, Zepbound, and Saxenda. Many employer plans leave it out.
A large share of UnitedHealthcare commercial members are in self-funded employer plans, where the employer — not UnitedHealthcare — decides whether anti-obesity drugs are covered. That's why two people with identical UnitedHealthcare cards can get opposite answers. If your plan did turn it on, here's what UnitedHealthcare's 2026 weight-loss policy requires:
- A BMI of 30 or higher, or a BMI of 27 or higher with a weight-related condition (like high blood pressure, high cholesterol, type 2 diabetes, or sleep apnea).
- The drug used alongside lifestyle changes — diet, exercise, or a weight-management program. Your chart has to note this.
- Prior authorization, every time.
Approval lengths are specific: UnitedHealthcare issues the first Wegovy approval for 5 months and the first Zepbound approval for 6 months. To renew, you generally need to show at least 5% body weight loss, then coverage extends for 12 months. A few states (like North Dakota individual plans) set a stricter starting bar of BMI 40+.
Six questions that get you a straight answer from your plan:
- Does my pharmacy benefit cover weight-loss (anti-obesity) medications at all?
- Are Wegovy, the Wegovy pill, Zepbound, or Saxenda on my plan for weight loss?
- Is weight-loss medication a flat exclusion on my plan?
- Does my plan use OptumRx?
- Does the drug I want need prior authorization or step therapy?
- If I'm denied, is it because of missing paperwork — or because the benefit is excluded?
Can Wegovy or Zepbound get covered if your plan "doesn't cover weight loss"?
Yes — sometimes. Even when weight-loss drugs are excluded, UnitedHealthcare has separate coverage rules for specific medical conditions. Wegovy can be covered to lower heart-attack and stroke risk, or to treat a liver disease called MASH. Zepbound can be covered for moderate-to-severe sleep apnea. These are real, written into UnitedHealthcare's 2026 policies — they just have their own strict criteria.
Zepbound for sleep apnea (one of the most useful doors)
If you have obesity and obstructive sleep apnea (OSA), UnitedHealthcare's sleep-apnea policy can cover Zepbound even when weight-loss coverage is excluded. To get the first 6-month approval, your records generally need to show:
- Age 18 or older and a BMI of 30 or higher.
- Moderate-to-severe OSA confirmed by a sleep study, with an apnea-hypopnea index (AHI) above 15.
- At least one past attempt to lose weight through diet.
- Either ongoing OSA symptoms despite using a CPAP/PAP machine (at least 4 hours a night, 70% of nights), or proof you can't use PAP.
- Use with diet and exercise, and no diabetes diagnosis (A1C 6.5% or under).
- A sleep specialist involved in the prescription.
To keep it past the first year, UnitedHealthcare wants your sleep numbers (AHI, RDI, or REI) to have dropped by at least half from where you started, plus at least 10% weight loss.
Wegovy for heart-attack and stroke prevention
If you have established heart disease, UnitedHealthcare's cardiovascular policy can cover Wegovy (pen or pill) to reduce the risk of heart attack and stroke — even on plans that exclude weight-loss drugs. The first 12-month approval generally requires:
- Age 45 or older and a BMI of 27 or higher.
- Proven heart disease — a prior heart attack, a prior stroke, or symptomatic peripheral artery disease.
- Already on the standard heart medicines your condition calls for — unless you can't tolerate them.
- Use with diet and exercise, and no diabetes (A1C 6.5% or under) and no severe (Class IV) heart failure.
Wegovy for liver disease (MASH)
UnitedHealthcare can also cover Wegovy injection for MASH (metabolic dysfunction-associated steatohepatitis — a serious fatty-liver disease). The criteria: F2 or F3 fibrosis documented within the past 12 months by a FibroScan, MRI elastography, or liver biopsy; the drug used with diet and exercise; not started at the same time as Rezdiffra for the same condition; and a gastroenterologist or hepatologist involved.
The takeaway: your diagnosis decides your door. If one is closed, ask your clinician — honestly, based on your real health history — whether another one fits.
First step, free. You now know the lanes. The fastest way to find yours — and exactly what to ask for — is our matcher.
See which coverage lane fits your situation →Free. 60 seconds. No signup.
How do I check my exact United Healthcare GLP-1 coverage?
The only reliable answer comes from your specific plan — and there are two fast ways to get it. Search the exact drug inside your UnitedHealthcare or OptumRx account, or have your doctor's office run a real-time check called PreCheck MyScript.
Know your plan type.
Employer/commercial, ACA marketplace, Medicare Advantage or Part D, or Medicaid/UHC Community Plan. The rules differ for each.
Search the exact drug in your portal.
Log into myuhc.com or the OptumRx app, open the pharmacy/drug section, and search each drug by name: Ozempic, Mounjaro, Rybelsus, Trulicity, Wegovy, Zepbound, Saxenda, Foundayo.
Read the result like a map.
See the table below for what each portal status means and your next move.
Have your doctor run PreCheck MyScript.
This tool lets your provider's office run a test claim on your exact plan to see your real price, coverage status, and whether prior authorization is needed — before the prescription ever reaches the pharmacy.
| What your portal shows | What it usually means | Your next move | Worth appealing? |
|---|---|---|---|
| Covered with prior authorization | Likely covered if you meet the rules | Ask your provider to submit the PA | N/A — not a denial |
| Non-preferred | Covered, but a cheaper option may exist | Ask which GLP-1 is preferred on your plan | Sometimes, via a formulary exception |
| Not covered | Off your formulary | Ask if a formulary exception is possible | Often worth a try |
| Benefit exclusion | Your plan doesn't pay for this category/use | Check the separate medical lanes or cash-pay options | Usually not — it's a benefit design, not a denial |
| Covered, high cost | A deductible or coinsurance issue | Ask for a copay estimate and savings options | N/A — it's covered |
| Your plan type | Where to check | What controls your coverage | Don't assume |
|---|---|---|---|
| Commercial / employer | myuhc.com, OptumRx, or ask your provider to run PreCheck MyScript | Your employer's pharmacy benefit design | That a coworker's coverage matches yours |
| ACA / Marketplace | Your plan's pharmacy benefit and documents | The specific plan you bought | That it works like an employer plan |
| Medicare Advantage / Part D | Your plan's formulary (search by ZIP code and plan) | Part D rules + the new Medicare GLP-1 Bridge | That weight-loss use is covered by standard Part D |
| Medicaid / UHC Community Plan | Your state's Medicaid/Community Plan pharmacy resources | Your state's rules | That another state's coverage applies to you |
Want help checking — or a plan B if you're not covered?
If you'd rather not navigate this alone, some FDA-approved telehealth programs will check your UnitedHealthcare coverage for you and handle the prior-authorization paperwork. The most complete option we verified for insurance-sensitive shoppers is Ro, which runs a free insurance check, employs an insurance team that submits prior authorizations, and offers FDA-approved medications you can pay cash for if your plan says no.
Let's be straight about the trade-off first, because it matters.
But because Ro keeps its membership cash-pay, it can do three things that solve the exact problem on this page:
- A free GLP-1 Insurance Coverage Checker. You enter your insurance details (no prescription, no commitment). Ro contacts your insurer and emails you a written report showing whether your GLP-1 is covered on your plan, your likely cost, and whether prior authorization is required.
- An insurance concierge that verifies your benefits and submits your prior authorization — Ro says this typically takes 1–3 weeks, and if you're covered, the prescription goes straight to your pharmacy.
- FDA-approved cash-pay options if your plan says no — so a denial doesn't send you back to square one.
| Ro says | What we verified | Keep in mind |
|---|---|---|
| Free insurance check | Ro's GLP-1 Insurance Coverage Checker contacts your insurer and returns a written coverage report; no prescription needed (ro.co, June 2026) | A report on coverage — not a guarantee of approval |
| Insurance concierge submits PA | Confirmed; Ro states the benefits-and-PA process takes about 1-3 weeks (ro.co, June 2026) | Timing varies by plan |
| Membership pricing | $39 first month, then as low as $74/month with an annual plan prepaid (otherwise $149/month) (ro.co, June 2026) | Cash-pay; not billed to insurance |
| Cash-pay medication | Wegovy pill from $149 first month; Foundayo from $149 first month; Zepbound KwikPen from $299 first month; Wegovy pen from $199 first month (ro.co, June 2026) | Medication billed separately from membership |
| FDA-approved formulary | Ro carries Zepbound (tirzepatide) and Foundayo (orforglipron), plus Wegovy pen and pill, at prices matching NovoCare, LillyDirect, and TrumpRx (ro.co, June 2026) | Ozempic prescribed off-label for weight loss only if clinically appropriate |
One patient featured in Ro's published coverage-checker report thought they'd owe about $1,000, then had Ro submit the prior authorization and point them to a savings card, and described payingjust $25at the pharmacy.Paid Ro testimonial. Individual experience — not a typical result and not a guarantee of coverage. The RX Index earns a commission if you start with Ro.
When you're ready to check — lowest-effort way to find out what your plan covers, without the phone-tag.
Check your UHC GLP‑1 coverage free with Ro → (sponsored affiliate link, opens in a new tab)Affiliate link. Free check. No prescription required.
What if United Healthcare denies your GLP-1?
A denial isn't one thing — and most aren't final. Get the denial reason in writing, then match it to this.
| If your denial says… | What it usually means | Can you fix it? | Your next move |
|---|---|---|---|
| Missing or incomplete information | A lab value, BMI, or note wasn't included | Often, yes | Ask your provider exactly what's missing and resubmit with it |
| Diagnosis/indication not met | The chart didn't support the lane (diabetes, OSA, heart risk, MASH) | Sometimes | Confirm the right lane matches your real records, then resubmit |
| Non-preferred / step therapy | The plan wants a different or cheaper GLP-1 first | Often | Ask which GLP-1 is preferred and whether it fits |
| Not covered / not on formulary | The drug isn't on your plan's list | Sometimes | Ask about a formulary exception with clinical justification |
| Benefit exclusion (weight-loss drugs) | Your plan doesn't pay for this category | Usually not by appeal | Check the separate medical lanes, or the cash-pay options below |
Your options if United Healthcare won't cover the GLP-1 you want
Option 1 — A different FDA-approved drug your plan covers
If Zepbound is denied but you have diabetes, ask whether Ozempic, Mounjaro, Rybelsus, or Trulicity is covered and appropriate. If one weight-loss drug is excluded, ask whether another (or the newer oral option, Foundayo, once it's added) sits on your formulary. Let your clinician decide what's medically right — don't switch on your own.
Option 2 — FDA-approved, cash-pay
If you want a brand-name, FDA-approved GLP-1 without fighting your benefit, cash-pay programs like Ro (above) and Sesame may offer certain FDA-approved options starting around $149/month for the medication, with program or membership fees separate. This keeps you on a real, FDA-approved drug even when insurance won't budge.
Option 3 — A separate, non-insurance treatment path (compounded)
This is a different category. Compounded semaglutide and tirzepatide are made by compounding pharmacies. They are not FDA-approved finished medications, they are not covered by UnitedHealthcare, and they should never be treated as interchangeable with Ozempic, Wegovy, Mounjaro, or Zepbound. Before choosing one, verify the current pricing, the pharmacy source, the clinician oversight, your state's rules, and the regulatory status.
Got a denial — or not sure what's next? Don't guess your way into the wrong path. Match your situation to your best next step in about a minute.
Find My GLP‑1 Path →Free. Compares FDA-approved and compounded paths with source-verified pricing.
What if I have United Healthcare Medicare, Medicaid, or an ACA plan?
Your plan type changes the rules completely. Standard Medicare can cover diabetes GLP-1s but historically not weight-loss use — though a new federal program changes that in mid-2026. Medicaid and UHC Community Plan coverage is set state by state.
UnitedHealthcare Medicare Advantage and the new Medicare GLP-1 Bridge
If you have a UnitedHealthcare Medicare Advantage plan, Part D can cover diabetes GLP-1s such as Ozempic and Mounjaro with prior authorization. By law, standard Part D has not covered GLP-1s prescribed only for weight loss.
That changes on July 1, 2026. The Medicare GLP-1 Bridge — a temporary federal program running through December 31, 2027 — gives eligible Part D members access to Wegovy (all forms), Foundayo (all forms), and the Zepbound KwikPen for weight loss at a flat $50 per month. A few things to know: a doctor must submit a Bridge prior authorization, the Bridge runs outside your normal Part D benefit, and the $50 you pay does not count toward your deductible or out-of-pocket maximum. Single-dose Zepbound vials and pens aren't included. CMS sets specific clinical criteria — generally a higher BMI, or a lower BMI combined with conditions like prediabetes or established heart disease — so ask your provider whether you qualify.
UnitedHealthcare Community Plan / Medicaid
Medicaid coverage is state-specific, and UHC Community Plan follows your state's rules. Don't assume — check your state's Medicaid drug list or call the number on your card.
UnitedHealthcare ACA / marketplace plans
Marketplace plans often differ from employer plans and may exclude weight-loss drugs. UnitedHealthcare's weight-loss policy also notes special state requirements (for example, California, New Mexico, New York, and North Dakota). Check your specific plan documents.
How we verified this United Healthcare GLP-1 coverage guide
We built this from UnitedHealthcare's own 2026 policies and federal sources — not from other blogs. We read UnitedHealthcare's commercial drug list, its diabetes and weight-loss prior-authorization programs, its two separate non-formulary pathways for Wegovy and Zepbound, and its pharmacy-update bulletin, and we pulled the exact criteria straight from those documents.
| Document (effective date) | What it answers | What it doesn't |
|---|---|---|
| UHC Commercial Prescription Drug List (May 1, 2026) | Which GLP-1s are listed, and their PA/QL flags | Whether your specific plan pays for them |
| Diabetes GLP-1 PA policy — Program 2025 P 1332-7 | The exact proof of diabetes UHC requires | Weight-loss coverage |
| Weight-loss medication policy — Program 2026 P 1114-20 (May 1, 2026) | BMI, lifestyle, and approval-length rules for Wegovy/Zepbound | Whether your employer elected the benefit |
| Zepbound sleep-apnea pathway — Program 2025 P 1475-2 (Mar 1, 2026) | The OSA criteria for Zepbound | Coverage on plans without the OSA diagnosis |
| Wegovy heart-risk & MASH pathway — Program 2026 P 1445-4 (May 1, 2026) | The cardiovascular and liver criteria for Wegovy | Weight-loss-only coverage |
| UHC commercial pharmacy update bulletin | What's changing (Byetta/Bydureon out 7/1/2026; Foundayo and Wegovy HD added 9/1/2026) | Your individual plan timing |
| CMS Medicare GLP-1 Bridge (beneficiary page) | Bridge drugs, $50 copay, dates, and TrOOP rules | Your exact eligibility before a provider checks |
✓ What we verified
- Drug listings, PA criteria, approval lengths, and the heart/liver/sleep-apnea pathways — all from UHC's 2026 documents.
- Medicare GLP-1 Bridge details from CMS's official beneficiary page (updated April 6, 2026).
- Ro's free insurance checker, concierge process, formulary, and cash-pay prices (ro.co, June 2026).
⚠ What we could not verify for you
- Your exact copay.
- Whether your employer turned on the weight-loss benefit.
- Whether your plan has special union, group, or state rules.
- Whether your specific prior authorization will be approved.
Frequently asked questions
Does United Healthcare cover Ozempic?
Usually, for type 2 diabetes, with prior authorization and proof of diabetes such as an A1C of 6.5% or higher. UnitedHealthcare does not cover Ozempic for weight loss, since it isn't FDA-approved for that use.
Does United Healthcare cover Mounjaro?
Mounjaro is on UnitedHealthcare's commercial drug list for type 2 diabetes with prior authorization and quantity limits. It's a diabetes drug, so weight-loss-only use generally isn't covered.
Does United Healthcare cover Wegovy for weight loss?
Only if your specific plan added a weight-loss drug benefit, and only with prior authorization and a qualifying BMI. Many employer plans exclude weight-loss drugs, but Wegovy can still be covered for heart-risk reduction or liver disease (MASH) under separate rules.
Does United Healthcare cover the Wegovy pill?
Yes, on the same terms as the Wegovy pen for plans that added weight-loss coverage -- UnitedHealthcare's 2026 weight-loss policy includes the Wegovy tablet. CMS also includes Wegovy tablets in the Medicare GLP-1 Bridge for eligible beneficiaries starting July 1, 2026.
Does United Healthcare cover Zepbound?
Zepbound may be covered for weight loss if your plan includes that benefit, or for moderate-to-severe obstructive sleep apnea under UnitedHealthcare's separate criteria, even when weight-loss coverage is excluded.
Does United Healthcare cover Foundayo?
Foundayo (orforglipron) is a newer oral GLP-1, FDA-approved in April 2026. It was not in UnitedHealthcare's May 2026 commercial weight-loss policy, but UnitedHealthcare is adding it to the weight-loss criteria effective September 1, 2026. It's also included in the Medicare GLP-1 Bridge starting July 1, 2026. Check your specific plan for current status.
Does United Healthcare cover GLP-1s for weight loss without diabetes?
Sometimes. It depends on whether your plan added the weight-loss medication benefit. If it didn't, a heart, liver, or sleep-apnea diagnosis may still open coverage.
Does United Healthcare cover compounded semaglutide or tirzepatide?
No. Compounded GLP-1s are not FDA-approved finished drugs and are not covered by UnitedHealthcare. They're a separate cash-pay path, not an insurance option.
How long does United Healthcare prior authorization take?
It varies by plan, by how complete your paperwork is, and by whether the request is urgent. Some clean requests are approved almost instantly through automated review; others take several business days.
What BMI do I need for United Healthcare to cover Wegovy or Zepbound?
Generally a BMI of 30 or higher, or 27 or higher with a weight-related condition. A few state plans set a higher starting bar, such as BMI 40+ on North Dakota individual plans.
Can a telehealth provider check my United Healthcare coverage for me?
Yes. Ro's free GLP-1 Insurance Coverage Checker contacts your insurer and returns a written report on whether your GLP-1 is covered and whether prior authorization is required, without writing a prescription during the free check.
What's the first thing I should do if I have United Healthcare and want a GLP-1?
Identify your plan type and your reason (diagnosis lane), then check the exact drug in your OptumRx account -- or use a free coverage checker -- before you book anything or pay out of pocket.
Still not sure which GLP-1 program is right for you? Take our free 60-second matching quiz.
Find My GLP‑1 Path →Free. No signup required. Personalized by insurance, budget, drug preference, and treatment path.
Sources
- UnitedHealthcare, Commercial Prescription Drug List (eff. May 1, 2026)
- UnitedHealthcare, Prior Authorization: Diabetes Medications GLP-1 & Dual GIP/GLP-1 Receptor Agonists (Program 2025 P 1332-7)
- UnitedHealthcare, Weight Loss Medications PA program (Program 2026 P 1114-20, eff. May 1, 2026)
- UnitedHealthcare, Zepbound for Obstructive Sleep Apnea (Program 2025 P 1475-2, eff. Mar 1, 2026)
- UnitedHealthcare, Wegovy Cardiovascular Risk Reduction and MASH (Program 2026 P 1445-4, eff. May 1, 2026)
- UnitedHealthcare, Commercial Pharmacy Update bulletin (Byetta / Bydureon removal eff. 7/1/2026; Foundayo and Wegovy HD additions eff. 9/1/2026)
- CMS, Medicare GLP-1 Bridge beneficiary information (updated April 6, 2026)
- Ro (ro.co) — insurance checker, concierge, and pricing (June 2026)
Also see: GLP-1 providers that work with UnitedHealthcare · How to bypass UHC step therapy for GLP-1s
Your situation changes the answer
Find My GLP-1 Path
The right GLP-1 provider isn't the same for everyone. It depends on your state, your insurance and formulary, whether you want an FDA-approved or compounded medication, your preferred route (injection or oral), and your budget. Because a general answer can't resolve those for you, use The RX Index's Find My GLP-1 Path tool to get a personalized provider match with source-verified pricing before you choose.
- What it asks: your state, insurance situation, medication preference, budget, and support needs
- What you get: a personalized shortlist of GLP-1 providers matched to your situation, with verified pricing and the right questions to ask
- Cost: free · about 60 seconds · no signup